1Eye Health

• Subject80 elderly male or female participants aged 45-65 years, with low MPOD levels (0.2 to 0.4)
• MethodTake Himalca™(Centella Asiatica extract) 300 mg/day for 180 days
  A double-blind, randomized, and placebo-controlled study

MPOD improvement beginning after 60 days (visit 2)

MPOD was significantly improved after 180 days
compared to the control group (P < 0.01)

[Clinical trial competed, preparing for submission to a journal]

2Liver Health

• Subject80 elderly male or female participants aged 20-70 years, with ALT level 45 ~ 135 U/L and AST level 25 U/L or higher in the previous 2 weeks
• MethodTake Himalca™(Centella Asiatica extract) 300 mg/day for 180 days
  A Randomized, Double-Blind, Placebo-Controlled Parallel study

• Before (Placebo)
• After (Placebo)
• Before (Himalca™)
• After (Himalca™)

ALT decreased 36.7%
AST decreased 27%
GGT decreased 18.8%

Lipid metabolism-related markers
TG and TC significantly decreased

Appl. Sci. 2021, 11, 11498.